Login

IsoRay, Inc ISR CEO Lori Woods on 2020 Results - Lori Woods , CEO, IsoRay Inc 00:00:00

Share On Facebook Share On Twitter

IsoRay, Inc ISR CEO Lori Woods on 2020 Results - Lori Woods , CEO, IsoRay Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"Insights and Updates: Javier Sáenz de Cenzano Discusses Fund Performance and Interviews New Manager Pavel Begun of 3G Capital"
00:10:00
Strategic Investments in the Baltics: Insights from NEPI Rockcastle's CEO Gijs Klomp | Gijs Klomp, CEO, NEPI Rockcastle NV.
00:10:00
Loomis Sayles’ Rick Razkowski on the Power of Research and Teamwork in Corporate Bond Strategies
00:10:00
Aston's Strategic Expansion in Canadian Nickel Mining
00:10:00
Khairussaleh Ramli's Strategy for Maybank's Future | Khairussaleh Ramli, CEO, Maybank .
00:10:00
From humble beginnings working in a candy store to co-founding a successful pharmaceutical company, Chintu's journey exemplifies perseverance, family support, and entrepreneurial spirit |Chintu Patel, CEO, Amneal Pharmaceuticals Inc.
00:10:00
Developing a Mine Responsibly: Efficient Water and Reagent Use with Minimal Environmental Impact
00:10:00
4GLOBAL CEO Eloy Mazon Discusses Interim Results and AI-Driven Growth | Eloy Mazon, CEO, 4GLOBAL PLC.
00:00:00
4d pharma reveals 'phenomenal results' from early stage cancer trial - Duncan Peyton, CEO, 4D Pharma
00:10:00
Talking Stocks: Exploring Investment Opportunities Across Key Sectors
00:10:00
Ask Marcin Jaśkiewicz: Live Q&A with Simteract SA’s President | Marcin Jaśkiewicz, President, Simteract SA.
00:10:00
AboitizPower CEO Manny Rubio discusses navigating the company through the pandemic and investing in renewable energy.

© 2017 - Neuhu+